Perspective Therapeutics, Inc. (CATX)
3.175
+0.02
(+0.47%)
USD |
NYAM |
Aug 27, 16:00
3.175
0.00 (0.00%)
After-Hours: 17:20
Perspective Therapeutics EPS Diluted (TTM) : -1.329 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.329 |
| March 31, 2026 | -1.396 |
| December 31, 2025 | -1.394 |
| September 30, 2025 | -1.458 |
| June 30, 2025 | -1.323 |
| March 31, 2025 | -1.209 |
| December 31, 2024 | -1.206 |
| September 30, 2024 | -1.007 |
| June 30, 2024 | -1.190 |
| March 31, 2024 | -1.030 |
| September 30, 2023 | -0.9283 |
| June 30, 2023 | -0.654 |
| March 31, 2023 | -0.3703 |
| June 30, 2022 | -0.5122 |
| March 31, 2022 | -0.4408 |
| December 31, 2021 | -0.4068 |
| September 30, 2021 | -0.3983 |
| June 30, 2021 | -0.3441 |
| March 31, 2021 | -0.4442 |
| December 31, 2020 | -0.4645 |
| September 30, 2020 | -0.4934 |
| June 30, 2020 | -0.511 |
| March 31, 2020 | -0.499 |
| December 31, 2019 | -0.5857 |
| September 30, 2019 | -0.6626 |
| Date | Value |
|---|---|
| June 30, 2019 | -0.7695 |
| March 31, 2019 | -1.006 |
| December 31, 2018 | -1.039 |
| September 30, 2018 | -1.128 |
| June 30, 2018 | -1.20 |
| March 31, 2018 | -1.10 |
| December 31, 2017 | -1.10 |
| September 30, 2017 | -1.10 |
| June 30, 2017 | -1.10 |
| March 31, 2017 | -1.00 |
| December 31, 2016 | -1.00 |
| September 30, 2016 | -0.90 |
| June 30, 2016 | -0.80 |
| March 31, 2016 | -0.80 |
| December 31, 2015 | -0.80 |
| September 30, 2015 | -0.80 |
| June 30, 2015 | -0.70 |
| March 31, 2015 | -0.8072 |
| December 31, 2014 | -1.107 |
| September 30, 2014 | -1.107 |
| June 30, 2014 | -1.607 |
| March 31, 2014 | -1.589 |
| December 31, 2013 | -1.289 |
| September 30, 2013 | -1.389 |
| June 30, 2013 | -1.089 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Anika Therapeutics, Inc. | -0.2741 |
| MiMedx Group, Inc. | 0.0395 |
| ABVC BioPharma, Inc. | -0.2878 |
| Enovis Corp. | -19.24 |
| Edwards Lifesciences Corp. | 1.685 |